Combining an exercise and nutritional intervention is arguably the optimal method of creating energy imbalance for weight loss. This study sought to determine whether combining exercise and caffeine supplementation was more effective for promoting acute energy deficits and manipulations to substrate metabolism than exercise alone. Fourteen recreationally active participants (mean Ϯ SD body mass index: 22.7 Ϯ 2.6 kg/m 2 ) completed a resting control trial (CON), a placebo exercise trial (EX), and a caffeine exercise trial (EXϩCAF, 2 ϫ 3 mg/kg of caffeine 90 min before and 30 min after exercise) in a randomized, double-blinded design. Trials were 4 h in duration with 1 h of rest, 1 h of cycling at ϳ65% power at maximum O2 consumption or rest, and a 2-h recovery. Gas exchange, appetite perceptions, and blood samples were obtained periodically. Two hours after exercise, participants were offered an ad libitum test meal where energy and macronutrient intake were recorded. EXϩCAF resulted in significantly greater energy expenditure and fat oxidation compared with EX (ϩ250 kJ; ϩ10.4 g) and CON (ϩ3,126 kJ; ϩ29.7 g) (P Ͻ 0.05). A trend for reduced energy and fat intake compared with CON (Ϫ718 kJ; Ϫ8 g) (P ϭ 0.055) was observed. Consequently, EXϩCAF created a greater energy deficit (P Ͻ 0.05). Caffeine also led to exercise being perceived as less difficult and more enjoyable (P Ͻ 0.05). Combining caffeine with exercise creates a greater acute energy deficit, and the implications of this protocol for weight loss or maintenance over longer periods of time in overweight/obese populations should be further investigated.
containing beverages a day (36) . Thus it is important and practical to examine what influence caffeine has on determinants of energy balance. There is strong evidence that caffeine can lead to subtle increases in resting EE (REE) (ϳ5% over 24 h) (28) . However, caffeine's effects on appetite and EI are more variable, with some studies reporting reductions in EI (47) , while others do not (23, 24, 26) ; however, these studies were all conducted in resting conditions. The mechanisms by which caffeine may influence appetite and EI remain unknown, but may be related to adenosine antagonism or changes in neurotransmitters, such as dopamine (22) . Although most of these studies did not incorporate measures of EE, alterations in resting metabolism, such as increased heart rate, fat oxidation, and skin temperature, have been documented with caffeine consumption (1, 3) .
A pair of studies examined the effect of 4 days of caffeine supplementation on spontaneous activity and EE, but observed no changes in these variables using a variety of assessment methods (31, 32) . While novel, these two studies were focused on free-living EE and nonexercise physical activity. The effect of caffeine supplementation on a structured exercise bout and the potential alterations in energy balance remain to be elucidated. Caffeine may also alter behavior via increasing enjoyment of physical activity (40) , which could be due to aforementioned changes in neurotransmitters and have implications for longer term exercise participation. This makes caffeine of particular interest as a potential nutritional intervention to utilize, in combination with exercise to manipulate energy balance. However, to our knowledge, no study has simultaneously examined how caffeine influences EE and EI in congruence with exercise.
Given the widespread habitual consumption of caffeine and the recommendations of exercise participation for health and weight loss and maintenance, examining the interactions of caffeine and exercise from an energy balance perspective may provide a highly practical strategy for creating acute and chronic energy deficits. Thus the aim of the present study was to examine how caffeine ingestion influences energy balance around an acute bout of exercise in recreationally active men and women. We hypothesized that caffeine supplementation with exercise would lead to higher EE and fat oxidation without alterations or compensation in EI, thereby creating a larger energy deficit than exercise alone.
METHODS
Overview. This study was a double-blind, randomized, placebocontrolled, crossover trial conducted according to the guidelines in the Declaration of Helsinki. All procedures were approved by the Griffith University Human Research Ethics Committee (GU protocol: PBH/ 52/13/HREC), and all participants provided written, informed consent before enrollment. Participants completed three experimental conditions a minimum of 3 days and maximum of 1 mo apart in a random order: a resting control trial (CON), a placebo exercise trial (EX), and a caffeine-exercise trial (EXϩCAF). A randomization sequence was generated using randomization software (http://www.randomizer. org/) for each participant. An individual not associated with data collection further randomized participants to caffeine or placebo treatment for each exercise trial. Procedures were identical for all trials, with the exception that no exercise was performed during the CON trial. Participants were informed that the purpose of the study was to examine the effects of exercise and caffeine on energy balance, and that EE would be measured during the laboratory visits. At the end of each visit, they were told that they would be given a free lunch. They were not informed this lunch was being measured until debriefing on completion of the study.
Familiarization and screening. Participants were required to be nonsmoking; nonobese [body mass (BM) index Ͻ30 kg/m 2 ], premenopausal (women), between 18 and 45 yr of age; not taking any medicine known to influence lipid, carbohydrate (CHO), or caffeine metabolism (except oral contraceptives); not dieting; weight stable in the previous 3 mo (Ϯ5% by self-report); no history of any cardiovascular or metabolic diseases; no food allergies or intolerances; no history of gastrointestinal disorders; and recreationally active (defined as Ն30 min of moderate-intensity exercise/day, Ն3 days/wk). Participants were recruited by e-mail advertisements through the university e-mail system. All participants completed preliminary paperwork on health, exercise, and dietary behaviors before attending any laboratory sessions.
Dietary restraint, dietary disinhibition, and susceptibility to hunger were assessed using the Three-Factor Eating Questionnaire (46) . Participants were excluded if they exceeded the cutoffs of 12, 9, and 8 for restraint, disinhibition, and hunger, respectively. Dietary caffeine intake was assessed using a caffeine consumption questionnaire to quantify daily consumption (13) .
Participants completed a familiarization and screening visit for determination of body composition, maximum O 2 consumption (V O2 max), and to be familiarized with the computer questionnaires utilized in the study. Informed consent was also obtained at this time. Height and weight were determined for calculation of BM index. Body density was determined via the sum of three skinfolds specific for sex using established equations (29, 30) . Percent body fat was calculated from body density utilizing the Siri equation (43) . Participants then mounted a cycle ergometer (Lode Excalibur Sport; Lode BV, Groningen, the Netherlands) and initiated exercise at 30 W for 3 min, after which workload was increased by 20 W/min (women) or 30 W/min (men) following a ramp protocol until volitional fatigue (cadence Ͻ 50 revolutions/min) was attained. Pedal cadence was maintained at 60 -90 revolutions/min, and participants were encouraged to exercise "all-out." Heart rate (Polar Electro, Kempele, Finland), O 2 consumption (V O2), CO2 production (V CO2), minute ventilation (V E), and respiratory exchange ratio (RER) (Quark C-PET; Cosmed, Italy) were monitored continuously. V O2 max attainment was confirmed with the following criteria: RER Ն 1.10, heart rate Ϯ 10 beats/min of age-predicted maximum, and/or a plateau in V O2 Ͻ 2.0 ml·kg Ϫ1 ·min Ϫ1 (39) . Standardization of diet and exercise. Before all experimental trials, participants were instructed to refrain from alcohol and caffeine intake for 24 h. Also in the 24 h before each trial, participants were asked to complete a food diary and record all food and drink. This diary was photocopied and returned to the participants, who were asked to replicate their intake for all subsequent trials. Food intake the 24 h before each trial was examined using dietary analysis software (FoodWorks, Xyris Software; Kenmore Hills, Queensland, Australia). Participants were also asked to refrain from strenuous exercise the 18 h before their trial, and this was confirmed through verbal compliance at the start of each trial.
Experimental trials. A timeline of the experimental trials is displayed in Fig. 1 . Participants arrived to the laboratory in the morning (0600 -0900) after an overnight fast (10 -12 h), having minimized physical activity en route. On arrival, participants completed visual analog scales for measures of mood, physical symptoms, and appetite while lying in a semisupine position. Simultaneously, a cannula was inserted into an antecubital vein for blood sample collection. Also at this time (during the exercise trials), 3 mg/kg BM of caffeine (PCCA, Matraville, NSW, Australia) or a placebo (Metamucil) were ingested with 250 ml of water. Our group has used this compound before as a texture-matched placebo with no reported issues, and the small amount of fiber (ϳ400 mg) likely had no influence on the variables examined. After giving participants ϳ20 min to rest quietly and acclimate, the participants began the first resting period of 60 min. REE was measured continuously for the final 20 min of this period using indirect calorimetry (Quark C-PET; Cosmed) and a facemask (V2 Mask; Hans-Rudolph), with the participants in a semisupine position, using suggested best-practice methods (9) . Coefficients of variation in our laboratory for REE, V O2, and V CO2 are 5.2, 4.8, and 5.6%, respectively.
Participants then completed 60 min of exercise on a cycle ergometer, at ϳ65% power output of V O2 max (EX and EXϩCAF) or rested/worked quietly (CON). During exercise, mechanical work and power output data were recorded continuously, while gas exchange (V O2, V CO2, RER) was recorded for the first 15 min and then from 25-35 min and 45-55 min. Power output was adjusted as necessary to maintain ϳ65% of the estimated power output at V O2 max. The attained power output from the first exercise trial was duplicated in the second one. At 15-min intervals, participants provided ratings of perceived exertion (RPE) (6), leg pain (10), and pleasure/displeasure (Feeling Scale) (27) ; heart rate was also recorded at these times. Enjoyment was assessed postexercise via completion of the Physical Activity Enjoyment Scale (PACES) (33) . During the equivalent period of the CON trial, gas exchange data were collected over the final 15 min to estimate EE; no perceptual measures were taken. Fig. 1 . Schematic of experimental trials. Syringes show when blood samples were obtained; pills show when caffeine dose (3 mg/kg body mass) was consumed; downward solid arrows represent visual analog scales for appetite; upward dashed arrow represents liquid breakfast at 150 min; gray boxes represent gas exchange data collection. Postexercise, gas exchange was measured throughout the final 15 min of each subsequent hour (ϩ165-180 and ϩ225-240 min). At ϩ150 min (30 min postexercise/rest), participants were given another 3 mg/kg BM dose of caffeine or placebo, along with a small liquid calorie meal (250 ml, 825 kJ, 30.3 g CHO, 3.8 g fat, 8.3 g protein; Up N Go, Sanitarium Health & Well-Being). This beverage was provided to provide participants with a small amount of calories and examine postprandial responses during all trials over the final 90 min. After the measurement period concluded (ϩ240 min), the cannula was removed, and participants were offered a lunch meal for the determination of single meal ad libitum EI. All trials were conducted in a thermoneutral laboratory environment (mean Ϯ SD: 23.3 Ϯ 0.5°C, 70.5 Ϯ 7.0% relative humidity, and 758.4 Ϯ 3.0 mmHg). Heart rate was recorded throughout the trials using short-range telemetry (Polar Electro).
The rationale for dividing the caffeine dosage was threefold. First, 3 mg/kg BM has been shown to improve exercise performance to the same degree as larger doses (15) . Second, by using multiple doses several hours apart, typical patterns of caffeine/coffee consumption are mirrored (i.e., early and midmorning coffee). A recent study reported that coffee consumption peaks in the morning (0600 -0800), with a second peak late morning (1000 -1200), with a decline thereafter during the week (25) . The third reason was to maintain plasma caffeine levels to examination their relationship to other variables.
Appetite perceptions. Starting at baseline and every 30 min throughout the trials, except for during the 60 min of exercise or rest, participants completed visual analog scales on a computer for appetite perceptions (hunger, fullness, satisfaction, desire to eat). After the lunch meal, ratings of pleasantness, palatability, and acceptability of the meal were also determined (Adaptive VAS, San Antonio, TX).
Blood sampling. Blood samples (8 total) were taken at baseline (Ϫ30 min), 15 min, preexercise (60 min), postexercise (120 min), 150 min, 180 min, 210 min, and prelunch (240 min). At each sample point, 3 ml of blood were collected into sodium fluoride tubes (BD Vacutainer; North Ryde, New South Wales, Australia) for determination of plasma glucose and lactate, and 4 ml into EDTA tubes (BD Vacutainer) for determination of plasma triglycerides. At baseline (Ϫ30 min), 15 min, preexercise (60 min), 180 min, and 240 min, an additional 3 ml of blood were collected into lithium heparin tubes (BD Vacutainer) for determination of plasma caffeine and paraxanthine (exercise trials; a baseline-only sample was collected during CON to ensure compliance regarding abstinence from caffeine intake). All samples were centrifuged at 10°C for 15 min at ϳ1,000 g, with the plasma stored at Ϫ80°C until analysis. Samples for plasma glucose (GLUC HK Gen. 3), lactate (LACT Gen. 2), and triglycerides (TRIGL) were analyzed in duplicate on a COBAS Integra 400 plus diagnostic system (Roche Diagnostics). Plasma caffeine and paraxanthine were determined using HPLC (14) in triplicate with standards of known concentration. Samples from each participant were analyzed within the same run to remove interassay variation. The intra-assay coefficients of variation were 3.8% for glucose, 3.6% for lactate, 4.0% for triglycerides, 5.2% for caffeine, and 6.7% for paraxanthine. Blood samples were not corrected for plasma volume, as exercise of comparable or greater duration and intensity has previously been shown not to result in acute plasma volume changes (7) .
Fluid and ad libitum EI. Fluid intake was standardized between trials. Participants were given 250 ml of water on arrival. A further 500 ml of water were provided during the exercise and rest (CON) period in two 250-ml servings (at 15 and 45 min) and another 250-ml serve between end-exercise and lunch (ϩ180 min). If participants did not consume all fluid offered in their first exercise trial, the amount consumed was replicated for the second one.
Two hours after exercise (240 min), participants were provided with an ad libitum meal for assessment of EI and instructed to eat until satisfied. Participants' were given their choice of a Subway sandwich and toppings (kept consistent between trials; sandwich and topping weights were not different, 545 Ϯ 90 g, P ϭ 0.632) and offered a number of side items, including savory, salty, and sweet foods, which may form part of a typical lunch meal (i.e., potato chips, apple, banana, and cookies). The sandwich portion of the meal was always fixed at one "foot-long" sandwich (12 in; 30.5 cm), but more side items were available if desired. Participants consumed their meals separately from the investigator or any other participants in a quiet environment. All food was weighed beforehand and presented in excess of expected consumption. Sandwiches were weighed as complete items. Food was weighed again after participants left the laboratory, and the manufacturers' values and a nutrition software database (FoodWorks, Xyris Software; Kenmore Hills, Queensland, Australia) were used to calculate energy and macronutrient intake.
Calculation of EE, substrate oxidation, and compensation. Gas exchange data, obtained via indirect calorimetry, was averaged in 30-s segments over the final 5 min of each 10-to 20-min collection period. Energy expenditure was quantified in the following increments: resting period (0 -60 min), exercise/control period (60 -120 min), postexercise recovery period 1 (120 -180 min), recovery period 2 (180 -240 min), and total trial (0 -240 min). Rates and total substrate oxidation were calculated for identical time periods using the equations of Frayn (21) and assuming negligible protein oxidation. Energy equivalents of 16.75 kJ/g of CHO and 37.68 kJ/g of fat were utilized to calculate EE from substrate oxidation.
Estimated relative EI (eREI) was calculated by subtracting EE from the EI of each trial. Postexercise energy compensation (PEEC) was calculated per the suggestion of Cadieux and colleagues (8) , as:
where EIexer is EI of the EX trials, EIctrl is EI of the CON trial, EEexer is total EE of the EX session, EEctrl is total EE of the CON session, and ExEE is the EE of the EX bout. Values below 100% would suggest incomplete compensation, whereas values greater than 100% suggest overcompensation.
Data analysis and statistics. Power calculations performed a priori suggested a minimum of 12 participants were necessary to detect a 500-kJ difference in ad libitum EI between treatments, with an estimated standard deviation of 1,000 kJ, at a power level of 80%.
Data were analyzed in an appropriate software package (SPSS version 22, Chicago, IL). Normality was tested using the ShapiroWilk test. Differences between men and women for demographic data were assessed using independent samples t-tests. One-way repeatedmeasures ANOVA explored differences between trials for total EE, substrate oxidation, energy and macronutrient intake, eREI, and area under the concentration-time curve (AUCs) for appetite perceptions and blood variables. Repeated-measures, two-factor (trial ϫ time) ANOVA examined changes between trials over time with the Bonferroni post hoc adjustment for multiple comparisons. The main aim of this study was not to examine differences between sexes or habitual caffeine intake, and the study lacked the power to do so. Mean differences between bouts of exercise and PEEC were examined with paired t-tests. Data in text and Tables 1-3 are presented as means Ϯ SD, whereas data in Figs. 1-4 are presented as means Ϯ SE for clarity and to avoid distortion. AUCs were calculated using the trapezoidal rule. Relationships between variables were examined using Pearson and partial correlations. Effect sizes for relevant comparisons (total EE, EI, relative EI, and exercise parameters) were calculated using Cohen's d and defined as trivial (Ͻ0.20), small (0.20 -0.40), moderate (0.40 -0.80), and large (Ͼ0.8), respectively. Differences were accepted as significant if P Ͻ 0.05 and all P values have already been adjusted for multiple comparisons.
RESULTS
Twenty-four participants were initially recruited and screened for the study. Seven participants failed to meet inclusion criteria (exhibited clinical levels of dietary restraint and disinhibition or medication usage). Seventeen completed screening and Effects of Caffeine and Exercise on Acute Energy Balance • Schubert MM et al. familiarization testing, but contact with one male participant was lost between screening and data collection. Another participant completed her first trial but withdrew thereafter due to a family emergency. Fifteen participants [8 women (3 using oral contraceptives); 7 men] completed all phases of the study. During data analysis, one male participant was discovered to have started all three of his trials with elevated plasma caffeine levels (44 SD above mean values). Therefore, this participant was excluded from analyses due to his noncompliance. Demographics of the remaining study participants (n ϭ 14) are displayed in Table 1 . Habitual caffeine intake was similar between sexes (P ϭ 0.925), but, due to differences in body weight, the men received a significantly greater dosage during the experimental trials (P Ͻ 0.005). Where possible, women completed all trials between days 1-14 of their menstrual cycle (n ϭ 4); when this was not possible, two trials were completed during the first phase, and the final trial during the same phase 3-4 wk later (n ϭ 4). The majority of participants (n ϭ 12) habitually exercised in the morning and in a fasted state. Dietary intake in the 24 h before each trial was well matched (CON:
Six participants had no idea or incorrectly guessed for which trial they had received caffeine. Four participants correctly identified their caffeine trials, but only had "some idea" of their certainty of having received caffeine. Three participants correctly reported they were "pretty sure" they had received caffeine. Finally, one participant correctly identified his caffeine trial and was "absolutely certain" he had received caffeine.
Energy expenditure and substrate oxidation. Energy expenditure and substrate oxidation for each measurement period and total trial are shown in Table 2 . Two-factor repeated-measures ANOVA revealed main effects of trial (P Ͻ 0.001), time (P Ͻ 0.001), and a significant trial ϫ time interaction (P Ͻ 0.001) for EE. Energy expenditure was higher during the exercise period and also the 2 h postexercise compared with the resting period (P Ͻ 0.01 for all). Furthermore, EE was higher during the resting period, exercise period, and the second postexercise recovery period in EXϩCAF compared with CON and EX (d ϭ 0.25-1.05). Total EE was significantly higher in EXϩCAF compared with EX (d ϭ 0.41) and CON (d ϭ 5.18), while EE during EX was also higher compared with CON (d ϭ 5.09) (P Ͻ 0.001 for all).
Regarding CHO oxidation, a main effect of trial (P Ͻ 0.001), time (P Ͻ 0.001), and a trial ϫ time interaction (P Ͻ 0.001) was revealed. Mean CHO oxidation was significantly elevated in EX and EXϩCAF compared with CON (P Ͻ 0.01 for both; d ϭ 5.04 and 4.94); these results were supported by the results for total CHO oxidation. CHO oxidation was significantly elevated during the exercise period compared with all other time points (P Ͻ 0.01 for all); CHO oxidation was also elevated in the final hour compared with rest and the first hour postexercise (P Ͻ 0.001 for both).
For fat oxidation, a main effect of trial (P Ͻ 0.001), time (P Ͻ 0.001), and a trial ϫ time interaction (P Ͻ 0.001) was observed. Mean fat oxidation was significantly greater for EXϩCAF compared with CON (P Ͻ 0.001) and EX (P ϭ 0.005) and was also higher for EX compared with CON (P Ͻ 0.001); this was supported by total fat oxidation results, which showed that EXϩCAF was greater than EX (d ϭ 0.98; P ϭ 0.005), with both having greater fat oxidation than CON (d ϭ 2.94 and 2.51; P Ͻ 0.001 for both). Fat oxidation was elevated at rest, during exercise, and during the second hour of recovery in EXϩCAF compared with EX and CON (d ϭ 0.75-1.21; P Ͻ 0.05 for all). EXϩCAF and EX fat oxidation were also elevated during the first hour of recovery compared with CON (P Ͻ 0.05). Values are means Ϯ SD; n, no. of subjects. BMI, body mass index; V O2max, maximum O2 consumption; TFEQ, Three-Factor Eating Questionnaire. *Significantly different from women (independent samples t-test; P Ͻ 0.05). Values are means Ϯ SD; n ϭ 14 subjects. CON, control; EX, exerciseplacebo; EXϩCAF, exercise-caffeine; EE, energy expenditure; CHO Ox, carbohydrate oxidation; Fat Ox, fat oxidation; RER, respiratory exchange ratio. *Mean value is significantly different from CON (P Ͻ 0.05). †Mean value is significantly different from EX (P Ͻ 0.05).
EI, relative EI, and PEEC. EI and macronutrient intake at the ad libitum lunch meal, eREI, and total weight of the meal consumed are displayed in Table 3 . Individual data for EI and eREI are displayed in Fig. 2 . Eight participants (4 men and 4 women) ate less in EXϩCAF compared with the other trials, 2 women consumed the least in CON, 2 participants (1 man and 1 woman) consumed the least in EX, and 2 participants (1 man, 1 woman) consumed similar amounts between trials.
One-way repeated-measures ANOVA revealed a significant difference between trials for EI (P ϭ 0.036). EI trended toward being lower in EXϩCAF compared with CON (d ϭ 0.51; P ϭ 0.055) but was not different for EXϩCAF compared with EX (d ϭ 0.44; P ϭ 0.109) ( Table 3 ). CHO (P ϭ 0.147) and PRO (P ϭ 0.344) intake were not significantly different between trials. A significant difference between trials was observed for fat intake (P ϭ 0.031); fat intake was significantly decreased in EXϩCAF compared with CON (P ϭ 0.04) and tended to be decreased compared with EX (P ϭ 0.06). Meal weights were significantly different between trials (P ϭ 0.032), with EXϩCAF significantly less than CON (d ϭ 0.42; P ϭ 0.05), but post hoc comparisons between EXϩCAF and EX (d ϭ 0.42; P ϭ 0.102) failed to reach significance.
Estimated REI was significantly different between trials, with the greatest energy deficit in the EXϩCAF condition compared with EX (d ϭ 0.71; P ϭ 0.033) and CON (d ϭ 3.0; P Ͻ 0.001). EX also had a greater deficit than CON (d ϭ 2.08; P Ͻ 0.001). Despite the differences in eREI, PEEC did not reach significance between the exercise trials (paired-samples t-test; P ϭ 0.110; d ϭ 0.41). Participants compensated for 85 Ϯ 36% of total EE in the EX trial and 71 Ϯ 32% of total EE in the EXϩCAF trial.
Appetite perceptions. Profiles for hunger and satisfaction are displayed in Fig. 3 . Baseline appetite perceptions were not significantly different between the trials (P Ͼ 0.3). Two-factor repeated-measures ANOVA revealed a main effect of time (P Ͻ 0.001), a significant trial ϫ time interaction (P ϭ 0.038), but no effect of trial (P ϭ 0.520) for hunger ratings during the trials. Hunger was higher in CON than EX and EXϩCAF at 30, 60, and 120 min (P Ͻ 0.05), while it was also higher in CON compared with EXϩCAF at 150 min (P Ͻ 0.05) (Fig. 3) . For satisfaction, a main effect of time (P ϭ 0.003) and a time ϫ trial interaction were also observed (P ϭ 0.002), but no effect of trial was detected (P ϭ 0.662). Ratings of satisfaction were higher at 120 and 150 min in EX and EXϩCAF compared with CON (P Ͻ 0.05) (Fig. 3) . Profiles for desire to eat and fullness showed similar effects (data not shown).
Total AUC for hunger was significantly different between trials (P ϭ 0.03), with CON higher than EXϩCAF (P ϭ 0.034). No other significant differences were observed in total appetite AUCs between trials.
Overall acceptance (palatability) of the meal was not significantly different between trials (CON: 80.4 Ϯ 12.9, EX: 80.4 Ϯ 12.6, EXϩCAF 80.5 Ϯ 13.1; P ϭ 0.999).
Plasma metabolites. Owing to difficulties with blood collection, complete blood sample data were available for eight participants (5 men; 3 women). Profiles for glucose, lactate, and triglycerides are displayed in Fig. 4 .
Baseline values for glucose (P ϭ 0.341), lactate (P ϭ 0.384), and triglycerides (P ϭ 0.66) were not significantly different between trials. Results showed a main effect of time (P Ͻ 0.001), but no effect of trial (P ϭ 0.097) or time ϫ trial interaction (P ϭ 0.413) for plasma glucose (Fig. 4) . Glucose levels at 180 min were significantly elevated compared with all other time points (first time point post-drink ingestion). Plasma lactate results revealed significant main effects for time (P Ͻ 0.001), trial (P ϭ 0.005), and a significant time ϫ trial interaction (P ϭ 0.014) (Fig. 4) . Lactate levels were significantly elevated at 120 min (postexercise) for EX (P ϭ 0.004) and EXϩCAF (P ϭ 0.013) compared with CON. For plasma triglycerides, a main effect of time (P Ͻ 0.001) and a significant time ϫ trial interaction (P ϭ 0.008), but no main effect of trial (P ϭ 0.051) (Fig. 4) , were observed. Triglycerides were significantly elevated in the EXϩCAF trial compared with CON at 60, 120, 210, and 240 min (P Ͻ 0.05) and also elevated above EX at 120 and 210 min (P Ͻ 0.05). During EX, triglycerides were elevated above CON at 120 and 240 min (P Ͻ 0.05).
Baseline values for caffeine and paraxanthine were not significantly different between trials (P Ͼ 0.4) and were Ͻ1.5 mol/l for caffeine, suggesting compliance with pretrial guidelines. In the EXϩCAF trial, caffeine levels peaked by 60 min (ϳ90 min posttreatment) at ϳ21 mol/l and were stable until increasing again between 180 and 240 min (30 -90 min post-second treatment ingestion), reaching a peak of ϳ33 mol/l by 240 min. Paraxanthine levels rose continuously throughout the EXϩCAF trial, reaching a peak concentration of ϳ8.1 mol/l at 240 min.
Other exercise responses. Exercise intensity (EX: 68.3 Ϯ 5.5, EXϩCAF: 68.4 Ϯ 3.7% V O 2 max ; P ϭ 0.92), V O 2 (EX: 2.18 Ϯ 0.40, EXϩCAF: 2.21 Ϯ 0.44 l/min; P ϭ 0.478), mechanical work (EX: 436 Ϯ 85, EXϩCAF: 437 Ϯ 82 kJ; P ϭ 0.714), and heart rate (EX: 145 Ϯ 18, EXϩCAF 148 Ϯ 14 beats/min; P ϭ 0.218) were well-matched between exercise trials. V E was increased (P ϭ 0.002; d ϭ 0.35) during EXϩCAF (58.1 Ϯ 9.5 l/min) compared with EX (54.7 Ϯ 10.5 l/min). Exercise during the EXϩCAF trial was perceived as less difficult (RPE EX: 14 Ϯ 2, EXϩCAF: 13 Ϯ 2; P ϭ 0.028, d ϭ 0.52) and more enjoyable (PACES EX: 87 Ϯ 17, EXϩCAF: 97 Ϯ 18; P ϭ 0.019, d ϭ 0.58), but pain (EX: 3.2 Ϯ 2, EXϩCAF: 2.6 Ϯ 2; P ϭ 0.092, d ϭ 0.31) and pleasure/displeasure (Feelin Scale EX: 1.9 Ϯ 2, EXϩCAF: 2.4 Ϯ 2; P ϭ 0.104, d ϭ 0.26) were not significantly different.
Relationships between variables. Correlational analyses revealed a number of relationships between variables. Pearson correlation analysis revealed a modest trend between fat oxidation and total triglyceride AUC (r ϭ 0.394; P ϭ 0.057), but this effect disappeared when controlling for trial (partial r ϭ 0.138; P ϭ 0.531). During the exercise bouts, we observed significant relationships between ventilation and EE (partial r controlling for trial ϭ 0.841, P Ͻ 0.001), fat oxidation and EE (partial r ϭ 0.495, P ϭ 0.009), and a trend for a relationship between ventilation and fat oxidation during exercise (partial r ϭ 0.350, P ϭ 0.074). In addition, measures of affect (pleasure/displeasure) were correlated with absolute EI (partial r ϭ Ϫ0.436, P ϭ 0.023), while enjoyment of physical activity was correlated with eREI (partial r ϭ Ϫ0.411, P ϭ 0.033). Finally, caffeine and paraxanthine AUCs were correlated with eREI (r ϭ Ϫ0.518 and Ϫ0.47, respectively; P Ͻ 0.025 for both), total fat oxidation (r ϭ 0.784 and 0.694; P Ͻ 0.001 for both), and total EE (r ϭ 0.537 and 0.48; P Ͻ 0.022 for both); however, none of these correlations remained significant after controlling for trial.
DISCUSSION
The present study aimed to examine the ability of caffeine supplementation to acutely manipulate EE, substrate metabolism, and EI in combination with a bout of moderate exercise in active individuals. The primary findings were that caffeine and exercise together led to significantly greater fat oxidation and EE, and a larger energy deficit compared with exercise alone. Additionally, EXϩCAF was also associated with changes to a number of perceptual variables during and after the exercise bout that may have beneficial implications for exercise enjoyment and participation.
A number of studies have demonstrated caffeine's ability to increase REE and metabolism (1, 3, 28) , which is likely mediated via activation of the sympathetic nervous system (SNS) (1). Our results confirm these findings, as the EXϩCAF trial had a higher EE in the time periods after caffeine ingestion (0 -60 and 180 -240 min). In addition, exercise EE was also significantly greater in EXϩCAF. Caffeine's ability to influence substrate metabolism, EE, ventilation, and V O 2 has been previously established at rest in men and women (2, 3) and during moderate intensity exercise (ϳ55% V O 2 max /65% maximum heart rate) in untrained men and women (17, 49) ; we extend these findings by establishing that caffeine before and after exercise, in a pattern of typical consumption, can increase EE and fat metabolism in recreationally active men and women before, during, and after moderate exercise. The implications of these differences in EE, and the potential time course that an increased EE would be sustained, require further investigation. It would also be interesting to compare habitual and nonhabitual caffeine consumers, since nonhabitual consumers may be more sensitive to the thermogenic effects of caffeine (51) . Habituation to caffeine and any changes in its effectiveness would also be worth investigating to see if the development of tolerance blunts changes in EE.
Regarding the closest available literature on caffeine supplementation and energy balance, a pair of studies revealed that caffeine supplementation (5 mg·kg BM Ϫ1 ·day Ϫ1 in two 2.5 mg/kg doses) led to nonsignificant decreases in EI (Ϫ490 and Ϫ880 kJ) and a trend for decreased fat intake in the second study (Ϫ13 g; P ϭ 0.052) over 4 days of supplementation (31, 32) . EI was assessed each day with 24-h food diaries and averaged for each 4-day condition (caffeine or placebo). However, these authors observed no changes in physical activity, nonexercise physical activity, total EE, steps per day, or REE during caffeine supplementation (31, 32) . The main explanation for the difference in EE results observed in the present study with caffeine supplementation and the results of Judice and colleagues (31, 32) could be that we utilized a structured, prolonged, moderate exercise bout in addition to caffeine to manipulate EE; therefore, caffeine and exercise synergistically manipulating the SNS may have had an additive effect on EE and EI.
Individuals are not driven to compensate for energy expended during exercise in the immediate hours (Ͻ12 h) after a single bout (19, 41) . Our present study supports these findings by revealing that participants only incompletely compensated for the exercise-induced energy deficit. Interestingly, a greater deficit was noticeable for EXϩCAF compared with EX and CON, and this appeared to be at least partially mediated by decreased fat consumption and increased fat oxidation. A study by Tremblay and colleagues (47) previously observed decreased energy and fat intake in men at a test meal 30 min after ingesting 300 mg of caffeine compared with placebo, but two other studies assessing acute effects of caffeine on single-meal EI did not achieve this result when using a single-item meal, which probably limited the ability to observe differences in macronutrient intake (Schubert MM, Grant G, Horner KM, King NA, Leveritt M, Sabapathy S, Desbrow B, unpublished observations; Ref. 5). Exercise and caffeine have both been examined for their hypothesized abilities to influence appetite perceptions (5, 7, 12) . In agreement with most research, the exercise bout in the present study caused a transient suppression of hunger and the desire to eat while simultaneously increasing satisfaction and fullness (7), but this effect was short-lived and had dissipated within 30 min. In contrast, caffeine ingestion had no additive effect on exercise-induced alterations in appetite, despite a significant reduction in fat consumption and a moderate, although not statistically significant, decrease in EI in the EXϩCAF trial compared with EX. Interestingly, changes in appetite perceptions do not appear to occur when caffeine and coffee are ingested at rest (23, 24) .
The ability of caffeine to manipulate some psychological variables is well established (45) . In agreement with prior research, we found caffeine attenuated RPE during exercise (16) and trended toward a reduction in muscle pain (37) . We also observed a trend for improved pleasure/displeasure as assessed via the Feeling Scale (27) , which is also in agreement with a prior study that utilized a similar exercise protocol in endurance-trained men (4) . Caffeine also improved enjoyment of physical activity, as assessed via a validated questionnaire (33) . Schrader and colleagues (40) previously reported, using Likert scales, that caffeine supplementation increased the liking of physical activity in sedentary women after 2 wk of caffeine paired with 30 min of moderate physical activity. The present study expanded these findings by showing that caffeine supplementation improved enjoyment of a moderate exercise task in recreationally active men and women. It has been reported that both pleasure and enjoyment are associated with exercise participation and compliance; thus caffeine supplementation may be a prospective strategy to improve participation (20) . Furthermore, these changes in enjoyment may be due to central effects of caffeine on adenosine and other neurotransmitters, such as dopamine (22) .
Exercise caused a significant perturbation in lactate levels, and this was independent of caffeine ingestion. Glucose levels were also unaffected by caffeine ingestion. Exercise led to significantly greater triglyceride levels compared with CON, and caffeine supplemented this increase. The increase in triglycerides or other markers of fat metabolism (glycerol/freefatty acids) has been observed in response to caffeine ingestion before (1, 17) , but whether increased appearance in the circulation is indicative of increased oxidation has been hotly debated. Although we observed a relationship between fat oxidation and triglycerides, correlation does not imply causation. Since this study did not use tracer methodology, the precise fate of the circulating triglycerides cannot be known.
There are a number of prospective mechanisms to support our findings that caffeine and exercise together result in significantly greater fat oxidation and EE, and a larger energy deficit compared with exercise alone. First, as mentioned above, caffeine has well-known influences on SNS activity, and this can lead to increased ventilation, lipid shuttling, and oxidation. Supporting this, a number of relationships between EE, ventilation, and fat oxidation were observed during exercise. Second, caffeine may manipulate mood by its antagonism of adenosine receptors and also increase serotonin and dopamine release (22, 35) ; higher dopamine levels may attenuate caloric intake or the drive to eat (11) . An increased positive affect has been associated with decreases in EI (48) , which were also observed in the present study. The ability of caffeine to influence neural networks may also have contributed to the reduction in EI, but this is purely speculative because, to our knowledge, no study has yet examined the influence of caffeine on brain areas involved in appetite and feeding behavior in response to food stimuli. Finally, caffeine has been shown to increase hippocampal brain-derived neurotropic factor, which has significant roles in the control of energy metabolism (34, 38) . Clearly, further research is required to understand the exact mechanisms underpinning the changes in EE and EI observed in the present study.
Limitations. The primary limitation of the present study is the relatively short duration of observation. We did not monitor physical activity, EE, or EI after the participants left the laboratory; thus we cannot exclude the possibility that participants may have compensated for exercise or control conditions by altering their activity patterns or food intake. However, the magnitude of any potential compensatory behaviors is likely to be small, given the conclusions of a recent systematic review on exercise and its impacts on nonexercise activity and EE (50) and results of earlier studies reporting that caffeine did not influence free-living EE or short bouts of voluntary physical activity (31, 32) . As EE was also extrapolated from intermittent measures, it may also be overestimated.
The other significant limitation of this study is that we did not include a resting caffeine condition. However, given the conclusions of the meta-analysis by Hursel and colleagues (28) on caffeine's influence on EE and fat metabolism, in addition to our prior work on caffeine/coffee and EI at rest (Schubert MM, Grant G, Horner KM, King NA, Leveritt M, Sabapathy S, Desbrow B, unpublished observations), it can be inferred that a resting caffeine condition may have shown a small increase in EE but no change in EI. Even if caffeine did increase resting EE and fat oxidation, the reported dose-response increases of 0.44 kJ/mg and 0.01 g/mg reported by Hursel et al. (28) (ϳ180 kJ and 4.1 g for the mean caffeine dose of this study) would likely not have resulted in a significant difference from the total energy expended during the CON trial, although it is possible fat oxidation may have been greater.
Finally, it must be noted that many individuals attain their dietary caffeine via coffee or other drinks that may have significant caloric value (i.e., lattes, colas, energy drinks) (36) . Therefore, future studies may wish to examine the role of these beverages in conjunction with exercise on metabolism and EI from an energy balance perspective.
Future directions. Future research should consider conducting similar investigations in overweight/obese individuals, since these individuals are the ones who are most in need of an intervention to improve body composition and compliance when beginning an exercise program. Manipulating the exercise mode, duration, and intensity with caffeine ingestion may also prove useful for determining the best strategy for a negative energy balance with minimal compensation, particularly if high-intensity training is used. Recent studies have suggested that high-intensity interval training does not lead to changes in short-term EI and may even decrease EI at a subsequent meal, and also elicits similar 24-h EE to traditional endurance exercise (12, 42, 44) . Caffeine ingestion may reduce the higher pain and perceived exertion associated with an interval training protocol and, based on our results, also increase enjoyment; this could possibly improve long-term compliance. The relationships between psychological variables related to exercise enjoyment, affect, and pleasure/displeasure also deserve further attention in an overweight/obese population; the ability to manipulate these variables in a positive manner via nutrition may prove highly useful for practitioners. Additionally, examining biomarkers of metabolism and energy regulation, such as brain-derived neurotropic factor, leptin, thyroid hormones, and gastrointestinal hormones, may provide mechanisms and insights into how caffeine and exercise interact to manipulate energy balance.
Conclusions. The results of this study indicate that consuming caffeine before and after a bout of moderate exercise increased EE and fat oxidation while improving exercise enjoyment. Nonsignificant decreases in EI were also observed with caffeine. While the increases observed in EE and fat oxidation compared with a normal exercise bout were relatively small, their effects over time could be important for weight maintenance and/or weight loss. The long-term implications of caffeine supplementation during an exercise program to improve participation and manipulate EE and substrate metabolism for weight loss and energy balance merit further investigation.
